Skip to content

Altimmune ALT Operating Lease Liabilities (Current)

Operating Lease Liabilities (Current) at other companies

Madrigal Pharmaceuticals, Inc. logo
Madrigal Pharmaceuticals, Inc.MDGL
$1.7M+67.0%
Viking Therapeutics logo
Viking TherapeuticsVKTX
$0-100%
Wave Life Sciences logo
Wave Life SciencesWVE
$8.33M+5.6%
Delcath Systems logo
Delcath SystemsDCTH
$92K-16.4%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$2.22M-32.6%
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
$2.35M+43.1%

Other financials

Income statement

See full
Revenue$26.0K+420%
Operating income-$24.2M-11.1%
Net income-$22.6M-15.3%
EPS (diluted)-$0.18+30.8%

Balance sheet

See full
Cash & equivalents$97.6M+98.7%
Total debt$34.8M+14,092%
Total equity$284.0M+99.8%
Total assets$335.6M+113%

Cash flow

See full
Operating cash flow-$20.9M-24.4%
CapEx$21.0K
Free cash flow-$21.0M

Valuation

See full
Market cap$558.14M-2.1%
Enterprise value$495.27M-5.0%
P/S13,613.2×-24,380×

Profitability

See full
Operating margin-230,461%-82,087pp
Net margin-214,861%-76,057pp
FCF margin-17,806.8%-110,030pp

Returns & leverage

See full
Return on equity-42.7%-8.7pp
Debt / equity0.1×+0.1×
Current ratio29.6×+13.7×

Where this comes from

Reported directly by Altimmune in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.

The official record: Altimmune’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Altimmune's operating lease liabilities (current).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Altimmune's operating lease liabilities (current)?
Altimmune (ALT) reported operating lease liabilities (current) of $265K in Q1 2026.
How has Altimmune's operating lease liabilities (current) changed year-over-year?
Altimmune's operating lease liabilities (current) increased by 8.2% year-over-year, from $245K to $265K.
What is the long-term trend for Altimmune's operating lease liabilities (current)?
Over 5 years (2020 to 2025), Altimmune's operating lease liabilities (current) has grown at a -6.4% compound annual growth rate (CAGR), from $356.72K to $256K.
What does operating lease liabilities (current) mean?
The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.